[144] Enovix Corp SEC Filing

Rhea-AI Filing Summary

Insider sale notice for Enovix Corp (ENVX). The filing reports that 120,000 common shares, originally issued as restricted stock units on 02/14/2024, are proposed to be sold under Rule 144 with an approximate market value of $1,555,200.00 based on the filing. The filer lists Morgan Stanley Smith Barney LLC as the broker and shows 120,000 shares were sold earlier under a Rule 10b5-1 plan on 10/02/2025 for gross proceeds of $1,441,416.00. The total shares outstanding shown are 196,600,013, so the proposed block represents about 0.06% of the outstanding common stock. The filer affirms they are not aware of any undisclosed material adverse information and references Rule 10b5-1 representations where applicable.

Positive

• Full disclosure of acquisition details: grant date 02/14/2024 and nature as Restricted Stock Units
• Broker identified: Morgan Stanley Smith Barney LLC listed for the proposed sale
• 10b5-1 sales recorded: prior sale on 10/02/2025 with gross proceeds of $1,441,416.00

Negative

• Insider liquidity event: planned sale of 120,000 shares for $1,555,200.00 reduces insider holdings
• Filing lacks issuer name and contact details in the provided tables, limiting context for investors

Insights

Securities Compliance Analyst

TL;DR: Insider sale of vested RSUs disclosed; structured sale history includes a 10b5-1 execution.

The notice shows 120,000 shares derived from restricted stock units granted on 02/14/2024, listed for sale through Morgan Stanley with an aggregate market value of $1,555,200.00. The filer also recorded a prior 10b5-1 sale of 120,000 shares on 10/02/2025 that generated $1,441,416.00 in gross proceeds.

Key dependencies are the accuracy of the acquisition dates, the use of a broker, and the 10b5-1 plan representation; these elements affect safe-harbor protections and timing compliance. Monitor any future filings that confirm final trade execution dates and amounts within the stated plan.

Equity Capital Markets Analyst

TL;DR: The disclosed sale size is immaterial to total float but indicates executive liquidity from RSUs.

Using the filing's outstanding share count of 196,600,013, the planned 120,000-share sale equals roughly 0.06% of the float, a small proportion unlikely to move market pricing by itself. The filing provides both the acquisition method (Restricted Stock Units) and the payment/acquisition date, which confirms these were company-granted awards.

Investors may note the near-term liquidity event but should await confirmations of executed trades and any additional filings that disclose cumulative insider sales over a wider timeframe.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	120000	1555200.00	196600013	10/07/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/14/2024	Restricted Stock Units	Issuer			120000	02/14/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for AJAY M MARATHE 3501 W Warren Avenue Fremont CA 94538	Common	10/02/2025	120000	1441416.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did the Enovix (ENVX) Form 144 disclose?

The filing reports a proposed sale of 120,000 common shares (RSUs granted 02/14/2024) with an aggregate market value of $1,555,200.00 and notes a prior 10b5-1 sale on 10/02/2025 for $1,441,416.00.

Who is handling the sale listed in the Form 144 for ENVX?

The broker named is Morgan Stanley Smith Barney LLC, with an address of 1 New York Plaza, 8th Floor, New York, NY 10004 as listed in the filing.

When were the securities acquired that are being sold under Rule 144?

The securities were acquired as Restricted Stock Units on 02/14/2024 and the filing shows payment/acquisition dated the same day.

How large is the proposed sale relative to Enovix's outstanding shares?

The filing lists 196,600,013 shares outstanding; 120,000 shares represent about 0.06% of that total.

Did the filer affirm compliance with Rule 10b5-1 representations?

Yes, the filer includes the standard representation that they do not possess undisclosed material adverse information and references 10b5-1 plan adoption or instructions where applicable.